← Leaderboards
Jeanne Sisk
University Of Maryland Baltimore
$166,690
Attributed
$166,690
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $59.2K · FY2015–17$100K$75K$50K$25K$0
'15
'16
'17
Funding mix
By agency
NIH$166,690 · 1
By mechanism
F32$166,690 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Syed Saif Hasan$1,678,506
- Stefanie N. Vogel$26,533,913
- Mohammad Mohseni Sajadi$9,238,668
- Myron Max Levine$22,681,817
- Roger Keith Reeves$28,096,305
Others in their field
Top investigators on “Effective Therapy”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lawrence Corey · Fred Hutchinson Cancer Center$467,028,615
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$263,149,639
- Constance Ann Benson · University Of California, San Diego$228,304,380
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
Effective TherapyBypassEffectivenessDrug UsageCell Culture TechniquesCellsBiosafety Level 3 FacilityAffectClathrinCathepsin LClinical TrialsCommon ColdCommunicable DiseasesConfocal MicroscopyCessation Of LifeCancer TypeChimeric ProteinsCoronavirus InfectionsCountryDasatinibCleaved CellDisease OutbreaksDrug Effect DisorderEndocytosis
Grant awards (4)
Repurposing of ABL kinase inhibitors for treatment of Coronavirus infections$59,166
F32 · FY2017 · AI · contact PI
Repurposing of ABL kinase inhibitors for treatment of Coronavirus infections$51,660
F32 · FY2016 · AI · contact PI
Repurposing of ABL kinase inhibitors for treatment of Coronavirus infections$3,458
F32 · FY2016 · AI · contact PI
Repurposing of ABL kinase inhibitors for treatment of Coronavirus infections$52,406
F32 · FY2015 · AI · contact PI